Purchasing Remicade (infliximab) online directly from manufacturers or authorized distributors is not generally feasible for individual patients. Remicade is a prescription medication administered intravenously, typically in a clinical setting, and requires strict handling and administration protocols. Online pharmacies may offer prescription medications, but it is crucial to verify their legitimacy and ensure they are licensed to dispense such treatments.
Where Can I Get Remicade If Prescribed?
If a healthcare provider prescribes Remicade, it is usually administered at a hospital, infusion center, or doctor's office [1]. This ensures proper medical supervision during administration and management of potential side effects. Patients should discuss with their doctor the process for obtaining Remicade, which may involve coordination with a specialty pharmacy or directly with the healthcare facility.
How Does Remicade Work?
Remicade is a tumor necrosis factor (TNF) blocker, a type of biologic medication. It works by targeting and blocking TNF-alpha, a protein that plays a key role in inflammation throughout the body. By reducing inflammation, Remicade helps to alleviate symptoms and slow disease progression in conditions like rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriatic arthritis, and ankylosing spondylitis [2].
What Are the Risks of Taking Remicade?
As with many powerful medications, Remicade carries potential risks. These can include serious infections, allergic reactions, heart failure, and certain types of cancer, particularly lymphoma and skin cancer [2]. Patients considering Remicade should have a thorough discussion with their doctor about their individual risk factors and the potential side effects.
When Does Remicade's Patent Expire?
Remicade's primary patents have expired in many regions, allowing for the development of biosimilars [3]. Information on specific patent expiry dates can be found on resources like DrugPatentWatch.com. The expiration of patents often leads to increased competition and potentially lower costs for biologic medications.
What Are Remicade Biosimilars?
Biosimilars are biological products that are highly similar to a reference biologic drug, like Remicade, with no clinically meaningful differences in safety, purity, or potency [4]. The development and approval of biosimilars can offer alternative treatment options for patients. Several infliximab biosimilars have been approved and are available in various markets.
Who Manufactures Remicade and its Biosimilars?
Remicade was originally developed and is marketed by Janssen Biotech, Inc., a subsidiary of Johnson & Johnson [2]. Various companies have since developed and market biosimilars to infliximab, each with their own manufacturing and distribution channels.
---
1. "Remicade (infliximab) Infusion Process." Janssen Biotech, Inc.
2. "Remicade." Janssen Biotech, Inc.
3. DrugPatentWatch.com.
4. U.S. Food and Drug Administration. "Biosimilar Medical Interventions."